Published in Clin Exp Immunol on October 01, 2005
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A (2007) 2.27
Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol (2007) 2.14
Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol (2009) 1.80
Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care (2009) 1.57
Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock. Clin Microbiol Rev (2009) 1.49
Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog (2012) 1.41
1alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology (2008) 1.33
Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect Immun (2007) 1.20
Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology. Am J Pathol (2011) 1.19
The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis. Crit Care (2013) 1.05
Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44. Front Immunol (2012) 0.99
HIV-1 and the immune response to TB. Future Virol (2013) 0.97
Topical p38 MAPK inhibition reduces bacterial growth in an in vivo burn wound model. Surgery (2007) 0.95
Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice. PLoS One (2010) 0.95
Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Ther (2006) 0.95
STAT3, p38 MAPK, and NF-kappaB drive unopposed monocyte-dependent fibroblast MMP-1 secretion in tuberculosis. Am J Respir Cell Mol Biol (2009) 0.95
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol (2012) 0.94
Matrix metalloproteinases and their inhibitors: promising novel biomarkers in severe sepsis? Crit Care (2009) 0.94
Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS One (2014) 0.93
Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin Exp Immunol (2008) 0.93
Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos. Genes Dev (2013) 0.91
Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol (2013) 0.91
Granulocyte-macrophage colony-stimulating factor- and tumor necrosis factor alpha-mediated matrix metalloproteinase production by human osteoblasts and monocytes after infection with Brucella abortus. Infect Immun (2010) 0.91
Multiple expression of matrix metalloproteinases in murine neurocysticercosis: Implications for leukocyte migration through multiple central nervous system barriers. Brain Res (2008) 0.88
Altered circulating levels of matrix metalloproteinases and inhibitors associated with elevated type 2 cytokines in lymphatic filarial disease. PLoS Negl Trop Dis (2012) 0.86
Matrix metalloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse. Hepatol Res (2009) 0.85
Osteolytic bone resorption in adult T-cell leukemia/lymphoma. Leuk Lymphoma (2010) 0.85
In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection. PLoS One (2011) 0.84
Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk. PLoS One (2011) 0.84
Matrix metalloproteinases with gelatinolytic activity induced by Paracoccidioides brasiliensis infection. Int J Exp Pathol (2009) 0.84
Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle. Reprod Biol Endocrinol (2012) 0.84
Immunological and viral features in patients with overactive bladder associated with human T-cell lymphotropic virus type 1 infection. J Med Virol (2012) 0.83
Matrix metalloproteinase 9 production by monocytes is enhanced by TNF and participates in the pathology of human cutaneous Leishmaniasis. PLoS Negl Trop Dis (2014) 0.82
Development of the first oligonucleotide microarray for global gene expression profiling in guinea pigs: defining the transcription signature of infectious diseases. BMC Genomics (2012) 0.82
Interaction of Leptospira interrogans with human proteolytic systems enhances dissemination through endothelial cells and protease levels. Infect Immun (2013) 0.80
Reaching the melting point: Degradative enzymes and protease inhibitors involved in baculovirus infection and dissemination. Virology (2015) 0.80
Genetic polymorphisms and sepsis in premature neonates. PLoS One (2014) 0.80
Functional characterization of Anopheles matrix metalloprotease 1 reveals its agonistic role during sporogonic development of malaria parasites. Infect Immun (2014) 0.79
LRP1 regulates remodeling of the extracellular matrix by fibroblasts. Matrix Biol (2009) 0.79
Inflammation in neuroviral diseases. J Neural Transm (Vienna) (2010) 0.78
Active-site MMP-selective antibody inhibitors discovered from convex paratope synthetic libraries. Proc Natl Acad Sci U S A (2016) 0.78
The Effector Protein BPE005 from Brucella abortus Induces Collagen Deposition and Matrix Metalloproteinase 9 Downmodulation via Transforming Growth Factor β1 in Hepatic Stellate Cells. Infect Immun (2015) 0.77
Anti-inflammatory effects of tetradecylthioacetic acid (TTA) in macrophage-like cells from Atlantic salmon (Salmo salar L.). BMC Immunol (2011) 0.76
Nitric oxide participation in granulomatous response induced by Paracoccidioides brasiliensis infection in mice. Med Microbiol Immunol (2009) 0.76
Irreversible airway obstruction assessed by high-resolution computed tomography (HRCT), exhaled nitric oxide (FENO), and biological markers in induced sputum in patients with asthma. Wien Klin Wochenschr (2014) 0.76
The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions. Clin Exp Immunol (2015) 0.75
Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition. Int J Mol Sci (2016) 0.75
Molecular cloning and characterization of a matrix metalloproteinase, from Caenorhabditis elegans: employed to identify homologous protein from Angiostrongylus cantonensis. Parasitol Res (2011) 0.75
Year in review 2013: Critical Care--sepsis. Crit Care (2014) 0.75
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function. World J Crit Care Med (2015) 0.75
Matrix metalloproteinases contribute to the regulation of chemokine expression and pulmonary inflammation in Cryptococcus infection. Clin Exp Immunol (2015) 0.75
Continuous Exposure to Low-Dose-Rate Gamma Irradiation Reduces Airway Inflammation in Ovalbumin-Induced Asthma. PLoS One (2015) 0.75
Virus infection drives IL-2 antibody complexes into pro-inflammatory agonists in mice. Sci Rep (2016) 0.75
Effect of Matrix Metallopeptidase 13 on the Function of Mouse Bone Marrow-derived Dendritic Cells. Chin Med J (Engl) (2017) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol (2004) 6.83
Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell (1996) 6.52
Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science (1999) 6.49
Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A (1962) 5.94
Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol (2002) 5.73
Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta (2000) 5.39
Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell (2002) 4.89
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (1994) 4.78
The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A (1990) 4.46
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature (1989) 4.42
Prostaglandins as modulators of immunity. Trends Immunol (2002) 4.15
Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (2000) 3.75
Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood (2002) 3.58
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol (1998) 3.04
HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci (2003) 2.66
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide. J Immunol (1979) 2.39
Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 (2000) 2.29
Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol (2001) 2.16
Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J (2004) 1.84
T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol (1995) 1.78
Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis (2000) 1.71
Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem (1996) 1.69
MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. J Clin Invest (2004) 1.65
Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain (2001) 1.65
Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun (2000) 1.63
Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia. Am J Respir Crit Care Med (2003) 1.63
Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax (1996) 1.61
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest (2002) 1.55
Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol (1999) 1.52
Stimulation of MMP-7 (matrilysin) by Helicobacter pylori in human gastric epithelial cells: role in epithelial cell migration. J Cell Sci (2003) 1.51
Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem (1998) 1.49
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest (2002) 1.47
Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem (1992) 1.46
Pro-collagenase-1 (matrix metalloproteinase-1) binds the alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem (2001) 1.46
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42
Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol (2000) 1.41
Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem (1994) 1.36
Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol (2003) 1.36
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol (1991) 1.34
Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology (2003) 1.34
Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med (1997) 1.33
Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Immunol (2003) 1.32
Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks. J Immunol (2003) 1.30
Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol (2001) 1.25
Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J Clin Invest (1991) 1.25
Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis. J Dent Res (1997) 1.24
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23
Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest (1991) 1.23
Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia. Glia (2003) 1.22
Blood-brain barrier function in cerebral malaria and CNS infections in Vietnam. Neurology (2000) 1.21
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol (2001) 1.20
Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem (1994) 1.19
Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun (2001) 1.17
Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect Immun (2001) 1.13
Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis (2002) 1.13
Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity. J Virol (2000) 1.12
Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am J Respir Crit Care Med (1999) 1.10
Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir Res (2004) 1.08
Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol (2000) 1.07
Activation of human matrix metalloproteinases by various bacterial proteinases. J Biol Chem (1997) 1.07
Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J Biol Chem (2001) 1.07
Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J Immunol (1995) 1.07
Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res (2003) 1.06
Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci (2000) 1.06
Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer (2002) 1.05
Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol (1996) 1.05
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol (1998) 1.05
A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection. Tuberculosis (Edinb) (2004) 1.04
HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol (2001) 1.04
Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis (1998) 1.03
Gelatinase B deficiency protects against endotoxin shock. Eur J Immunol (2002) 1.03
Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood (2001) 1.03
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol (2004) 1.02
Differential expression of matrix metalloproteinases in bacterial meningitis. Brain (1999) 1.02
Inhibition of matrix metalloproteinases by chemically modified tetracyclines in sepsis. Shock (2003) 1.02
HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol (1996) 1.01
Matrix metalloproteinase inhibition. From the Jurassic to the third millennium. Ann N Y Acad Sci (1999) 1.01
Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res (1991) 0.98
Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix. J Immunol (2004) 0.98
Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis. Microb Pathog (2000) 0.98
HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol (1995) 0.98
Host metalloproteinases in Lyme arthritis. Arthritis Rheum (2001) 0.98
Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infect Immun (2004) 0.97
Helicobacter pylori upregulates matrilysin (MMP-7) in epithelial cells in vivo and in vitro in a Cag dependent manner. Gut (2003) 0.97
Dynamics of collagen, MMP and TIMP gene expression during the granulomatous, fibrotic process induced by Schistosoma mansoni eggs. Ann Trop Med Parasitol (2004) 0.96
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia. Brain (2003) 0.96
Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J Neuroimmunol (2000) 0.94
Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology (2004) 0.94
Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production. J Immunol (1990) 0.93
Activation of macrophage promatrix metalloproteinase-9 by lipopolysaccharide-associated proteinases. J Immunol (2002) 0.92
Interleukin 1beta induces gastric epithelial cell matrix metalloproteinase secretion and activation during Helicobacter pylori infection. Gut (2003) 0.92
Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs. J Biol Chem (2005) 0.92
Tuberculous bronchoesophageal fistulae in patients infected with the human immunodeficiency virus: three case reports and review. Clin Infect Dis (1994) 2.44
Matrix metalloproteinases in destructive pulmonary pathology. Thorax (2005) 2.06
Health-care provision for asylum seekers and refugees in the UK. Lancet (1999) 1.89
Refugees, asylum seekers, and general practice: room for improvement? Br J Gen Pract (2000) 1.80
Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J Immunol (1999) 1.46
Alveolitis associated with sulphamethoxypyridazine. Thorax (1989) 1.39
Matrix metalloproteinases in tuberculosis. Eur Respir J (2011) 1.28
High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J (2008) 1.22
Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol (2001) 1.20
Europe's health-care lottery. Lancet (2001) 1.08
Controversies in the management of cysticercosis. Emerg Infect Dis (1997) 1.07
Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis. J Infect Dis (1998) 1.06
Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J (2011) 1.06
Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells. J Gen Virol (1994) 1.01
Spontaneous breast abscess due to Mycobacterium fortuitum. Clin Infect Dis (1998) 0.98
Monitoring compliance with antituberculous treatment by detection of isoniazid in urine. Lancet (1997) 0.95
Filter sterilization of highly infectious samples to prevent false negative analysis of matrix metalloproteinase activity. J Immunol Methods (2005) 0.94
Basic epidemiology and immunopathology of RSV in children. Paediatr Respir Rev (2000) 0.93
Elevated plasma interleukin 8 in respiratory syncytial virus bronchiolitis. Pediatr Infect Dis J (1995) 0.91
Down-regulation of interleukin-8 secretion from Mycobacterium tuberculosis-infected monocytes by interleukin-4 and -10 but not by interleukin-13. Infect Immun (2001) 0.91
Modulation of HIV transcription in and release from human monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res Virol (1993) 0.91
Hiccups, toxoplasmosis, and AIDS. Clin Infect Dis (1994) 0.91
Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells. Cytokine (2000) 0.90
Changes in arterial K+ and ventilation during exercise in normal subjects and subjects with McArdle's syndrome. J Physiol (1990) 0.89
Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection. J Virol (2000) 0.87
Elevated concentrations of eotaxin and interleukin-5 in human neurocysticercosis. Infect Immun (1998) 0.86
Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation. J Virol (1993) 0.84
Pseudomyxoma peritonei. J R Soc Med (1986) 0.83
Immunology of Taenia solium taeniasis and human cysticercosis. Parasite Immunol (2014) 0.83
Local and systemic concentrations of tumour necrosis factor-alpha, interleukin-6 and interleukin-8 in bacterial osteomyelitis. Trans R Soc Trop Med Hyg (2000) 0.82
Grand rounds--Hammersmith Hospital. Persistent fever in pulmonary tuberculosis. BMJ (1996) 0.82
Q fever and intrauterine death. Lancet (1994) 0.79
TB still a global killer. Nature (1997) 0.79
Fishing injury resulting in Mycobacterium fortuitum palmar abscess. Eur J Clin Microbiol Infect Dis (2007) 0.78
CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology (2011) 0.77
Whole-blood assays for cytokine production. Methods Mol Med (2000) 0.77
The ventilatory response to lowering potassium with dextrose and insulin in subjects with hyperkalaemia. Respir Physiol (1989) 0.76
Presumed Pott's disease. Lancet (1996) 0.75
Further echoes of the Spanish lady. Lancet (1996) 0.75
Exertional fatigue in disorders of muscle. N Engl J Med (1991) 0.75
Directly observed treatment for tuberculosis. Treatment strategies will need to be changed because of drug resistance. BMJ (1996) 0.75
Cytokine therapy in septic shock. N Engl J Med (1995) 0.75
Upper respiratory tract infections. Curr Opin Pulm Med (1999) 0.75
Astrocyte-leucocyte interactions and the mechanisms regulating matrix degradation in CNS tuberculosis. Biochem Soc Trans (2007) 0.75
Obliterative bronchiolitis and alveolitis associated with sulphamethoxypyridazine (Lederkyn) therapy for linear IgA disease of adults. Br J Dermatol (1990) 0.75